STOCK TITAN

FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES NEW WOUND CARE SERVICES OFFERING

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
FOXO Technologies Inc. (NYSE American: FOXO) has announced that its Big South Fork Medical Center in Oneida, Tennessee, has begun offering wound care services for both inpatient and outpatient treatment. The expansion addresses growing demand in the service area, particularly focusing on diabetic patients who face challenges with wound healing due to excessive inflammation and reduced angiogenesis. CEO Seamus Lagan indicated that this service expansion is expected to increase net revenues, and the company is exploring additional service offerings at the Oneida campus and other regional locations.
FOXO Technologies Inc. (NYSE American: FOXO) ha annunciato che il suo Big South Fork Medical Center a Oneida, Tennessee, ha iniziato a offrire servizi di cura delle ferite sia per pazienti ricoverati che ambulatoriali. Questa espansione risponde alla crescente domanda nell'area di servizio, con particolare attenzione ai pazienti diabetici che affrontano difficoltà nella guarigione delle ferite a causa di un'infiammazione eccessiva e una ridotta angiogenesi. Il CEO Seamus Lagan ha indicato che questa espansione dei servizi dovrebbe incrementare i ricavi netti, e l'azienda sta valutando ulteriori offerte di servizi nel campus di Oneida e in altre sedi regionali.
FOXO Technologies Inc. (NYSE American: FOXO) ha anunciado que su Big South Fork Medical Center en Oneida, Tennessee, ha comenzado a ofrecer servicios de cuidado de heridas tanto para pacientes hospitalizados como ambulatorios. Esta expansión responde a la creciente demanda en el área de servicio, enfocándose especialmente en pacientes diabéticos que enfrentan dificultades en la cicatrización debido a una inflamación excesiva y una angiogénesis reducida. El CEO Seamus Lagan indicó que se espera que esta expansión de servicios aumente los ingresos netos, y la compañía está explorando ofrecer servicios adicionales en el campus de Oneida y en otras ubicaciones regionales.
FOXO Technologies Inc. (NYSE American: FOXO)는 테네시주 오네이다에 위치한 Big South Fork Medical Center가 입원 환자와 외래 환자를 위한 상처 치료 서비스를 시작했다고 발표했습니다. 이번 서비스 확대는 특히 과도한 염증과 감소된 혈관 생성으로 인해 상처 치유에 어려움을 겪는 당뇨병 환자들을 중심으로 서비스 지역 내 증가하는 수요를 충족하기 위한 것입니다. CEO 시머스 라간은 이번 서비스 확장이 순수익 증가에 기여할 것으로 기대하며, 회사는 오네이다 캠퍼스 및 기타 지역 지점에서 추가 서비스 제공도 모색 중이라고 밝혔습니다.
FOXO Technologies Inc. (NYSE American : FOXO) a annoncé que son Big South Fork Medical Center à Oneida, Tennessee, a commencé à proposer des services de soins des plaies pour les patients hospitalisés et ambulatoires. Cette expansion répond à une demande croissante dans la zone de service, en se concentrant particulièrement sur les patients diabétiques qui rencontrent des difficultés de cicatrisation en raison d'une inflammation excessive et d'une angiogenèse réduite. Le PDG Seamus Lagan a indiqué que cette extension des services devrait augmenter les revenus nets, et la société explore la possibilité d'offrir des services supplémentaires sur le campus de Oneida et dans d'autres sites régionaux.
FOXO Technologies Inc. (NYSE American: FOXO) hat bekannt gegeben, dass sein Big South Fork Medical Center in Oneida, Tennessee, nun Wundversorgung sowohl für stationäre als auch ambulante Patienten anbietet. Diese Erweiterung reagiert auf die steigende Nachfrage im Versorgungsgebiet, wobei der Fokus insbesondere auf diabetischen Patienten liegt, die aufgrund von übermäßiger Entzündung und verringerter Angiogenese Schwierigkeiten bei der Wundheilung haben. CEO Seamus Lagan gab an, dass diese Serviceerweiterung voraussichtlich die Nettoumsätze steigern wird, und das Unternehmen prüft zusätzliche Serviceangebote am Standort Oneida sowie an weiteren regionalen Standorten.
Positive
  • Expansion of medical services to include wound care treatment, addressing growing market demand
  • Focus on serving diabetic patients, a significant market segment with specific wound care needs
  • Expected increase in net revenues from new service offering
  • Potential for further service expansion at Oneida campus and other regional locations
Negative
  • None.

WEST PALM BEACH, FLORIDA, June 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its critical access hospital, Big South Fork Medical Center located in Oneida, Tennessee, has commenced offering wound care services to patients both on an inpatient and outpatient basis. The hospital has experienced a growing demand for wound care services in its market service area, particularly for diabetic patients who have wounds often characterized by excessive inflammation and reduced angiogenesis and have a higher risk for postoperative wound healing complications.

“We are pleased that our critical access hospital in rural, East Tennessee is expanding its services that will, in turn, increase net revenues and we are working closely with hospital leadership to further expand our market reach which may include other, needed service offerings at our Oneida campus or other locations in the region,” stated Seamus Lagan, Chief Executive Officer of parent company, FOXO Technologies Inc.

About FOXO Technologies Inc. (“FOXO”)

FOXO owns and operates three subsidiaries.

Rennova Community Health, Inc., owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), a critical access designated (CAH) hospital in East Tennessee.

Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.

FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.

For more information about FOXO, visit www.foxotechnologies.com.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Sebastien Sainsbury
ssainsbury@foxotechnologies.com
(561) 485-0151


FAQ

What new services is FOXO Technologies (FOXO) adding to its Big South Fork Medical Center?

FOXO Technologies is adding wound care services for both inpatient and outpatient treatment at its Big South Fork Medical Center in Oneida, Tennessee.

How will the new wound care services affect FOXO Technologies' revenue?

According to CEO Seamus Lagan, the new wound care services are expected to increase net revenues for the company.

What specific patient group is FOXO Technologies targeting with its new wound care services?

The services particularly target diabetic patients who face challenges with wound healing due to excessive inflammation and reduced angiogenesis.

What are FOXO Technologies' future expansion plans for Big South Fork Medical Center?

The company is working with hospital leadership to expand market reach, potentially including additional service offerings at the Oneida campus and other locations in the region.
FOXO TECHNOLOGIES

NYSE:FOXO

FOXO Rankings

FOXO Latest News

FOXO Stock Data

3.38M
10.43M
9.9%
2.69%
8%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States
WEST PALM BEACH